This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This PTPRCAP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 90-118 amino acids from the Central region of human PTPRCAP.
PTPRCAP
Reactivity: Human
WB, EIA
Host: Rabbit
Polyclonal
unconjugated
Application Notes
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.48 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
PTPRCAP
(Protein tyrosine Phosphatase, Receptor Type, C Polypeptide-Associated Protein (PTPRCAP))
AI605264 antibody, CD-45-AP antibody, LPAP antibody, LSM-1 antibody, CD45-AP antibody, protein tyrosine phosphatase, receptor type, C polypeptide-associated protein antibody, protein tyrosine phosphatase, receptor type C associated protein antibody, protein tyrosine phosphatase, receptor type, C-associated protein antibody, Ptprcap antibody, PTPRCAP antibody
Background
The protein encoded by this gene was identified as a transmembrane phosphoprotein specifically associated with tyrosine phosphatase PTPRC/CD45, a key regulator of T- and B-lymphocyte activation. The interaction with PTPRC may be required for the stable expression of this protein.